Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis

Cancer

Volumn 88, Issue 11, 2000, Pages 2512-2519

  Beaujard, Annie C ^a,b   Glehen, Olivier ^b   Caillot, Jean L ^a   Francois, Yves ^a,b   Bienvenu, Jacques ^a,b   Panteix, Gilles ^b   Garbit, Florence ^a,b   Grandclément, Eric ^a,b   Vignal, Jacques ^a   Gilly, François N ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Digestive tract cancer; Hyperthermia; Intracavitary hyperthermia; Intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CANCER MORTALITY; CANCER STAGING; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL TIME;

EID: 18744436033     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J     Document Type: Article

References (27)

1. Iitsuka Y, Kaneshima S, Tanida O. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979; 44:1476-80.
2. Chu DZ, Lang NP, Thompson C. Peritoneal carcinomatosis in nongynecologic malignancies: a prospective study of prognosis factors. Cancer 1989;2:364-7.
3. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the Evocape 1 multicentric prospective study. Cancer 2000;88:360-5.
4. Torisu M, Katano M, Kimura Y. New approach to management of malignant ascites with a streptococcal preparation OK 432: improvement of host immunity and prolongation of survival. Surgery 1983;93:357-64.
5. Hagiwara A, Takahashi T, Lee R. Chemotherapy of carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C absorbated on activated carbon particles. Cancer 1987;59: 43-9.
6. Sugarbaker P. Peritonectomy procedures. Ann Surg 1995; 221:29-42.
7. Koga S, Hamazoe R, Maeta M. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with anticancer drugs. Cancer Res 1984;44:1840-2.
8. Fujimoto S, Shrestha RD, Kokubun M. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seedings. Ann Surg 1988;208:36-41.
9. Crile G. The effect of heat and radiation on cancers implanted in the feet of mice. Cancer Res 1963;23:372-80.
10. Barlogie B, Corry PM, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cisdichlorodiamineplatinium. Cancer Res 1980;40:1165-8.
11. Teicher BA, Kowal CD, Kennedy KA. Enhancement by hyperthermia of the in vitro cytoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41:1096-9.
12. Gilly FN, Carry PY, Sayag AC. Intraperitoneal chemohyperthermia with mitomycin C in dogs: general, biological and anastomotic tolerance. Int J Hyperthermia 1992;8:659-66.
13. Gilly FN, Carry PY, Sayag AC. Regional chemotherapy with mitomycin C and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 1994;41:124-9.
14. Panteix G, Guillaumont M, Cherpin L. Study of the pharmacokinetics of MMC in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology 1993;50:366-70.
15. Fujimoto S, Takahashi M, Mutou T. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79:884-91.
16. Schneebaum S, Arnold MW, Staubus A. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol 1996;3:44-50.
17. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer 1994;73:2048-52.
18. Jacquet P, Stephens AD, Averbach AM. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996;77:2622-9.
19. Mansvelt B, Bertrand C, Nackermann P. Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis. Ann Chir 1997;51:60-7.
20. Sugarbaker P, Zhu BW, Banez Seze G. Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 1993;36:323-9.
21. Elias D, Detroz B, Debaene B. Treatment of peritoneal carcinomatosis by intraperitoneal chemohyperthermia: reliable and unreliable concepts. Hepatogastroenterology 1994;41:207-13.
22. Fernadez Trigo V, Stuart OA, Stephens AD. Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C. Cancer Treat Res 1996;81:51-61.
23. Otani S, Maeta M, Oka A. Long term survival of 5 years following initial surgery for gastric cancer and simultaneous disseminated peritoneal metastasis. Surg Today 1995;25: 959-61.
24. Yonemura Y, Fujimura T, Fuschida S. Hyperthermochemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530-6.
25. Fujimoto S, Takahaschi M, Kobayaschi K. Combined treatment of pelvic exenterative surgery and intraoperative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case. Surg Today 1993;23: 1094-8.
26. Kuzuya T, Yamauchi M, Ito A. Pharmacokinetic characteristics of 5-fluorouracil and MMC in intraperitoneal chemotherapy. J Pharm Pharmacol 1994;46:685-9.
27. Elias D, Gachot B, Bonvallot S. Peritoneal carcinomatosis treated by complete excision and immediate postoperative intraperitoneal chemotherapy: Phase II study in 54 patients. Gastroenterol Clin Biol 1997;11:181-7.